Latest Breaking News On - Perceptive xontogeny venture fund - Page 7 : comparemela.com

Ginkgo unveils its stock ticker, a biotech venture fund raises $515m, and a unicorn is born By Anissa Gardizy Globe Staff,Updated May 14, 2021, 2 hours ago Email to a Friend Jason Kelly, cofounder and chief executive of Ginkgo Bioworks.Scott Eisen/Bloomberg Here’s a roundup of five local life-science deals and fundraising events that people are talking about this week. Ginkgo Bioworks After announcing a $17.5 billion merger with a SPAC (blank check company) earlier this week, Ginkgo Bioworks on Friday (finally) unveiled its stock ticker as it plans to go public: “DNA.” The biotech explained in a Twitter thread why it chose the ticker, which was first used by Genentech before it was acquired, and why it decided against more obvious trading symbols, such as “GKGO” or “CELL.”

United statesUnited arab emiratesUnited kingdomAl iskandariyahNexcelom bioscienceJason kellyChris garabedianInvestment corporation of dubaiAmazon web servicesPerceptive xontogeny venture fundApp storeFlagship pioneering backedBoston business journalAlexandria venture investmentsInvestment corporationPavilion capita